Emergent Biosolutions Inc (EBS)

CapEx to Revenue

0.90%

Quarterly · Period ending:

EBS logo

EBS CapEx to Revenue

Latest reported0.90%
EBS Quarterly CapEx/Revenue (0.00% → 0.90%)
High-resolution chart · PNG

EBS capex to revenue history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Emergent Biosolutions Inc CapEx to Revenue — Quarterly
Period endingCapEx to Revenue
0.8963%
1.5375%
2.6227%
1.4712%
2.0582%
1.6202%
0.8731%
1.9741%
1.806%
3.5952%
4.1215%
4.658%
3.6993%
9.1905%
13.7492%
11.6298%
13.3806%
10.4715%
6.4574%
16.7781%
16.8553%
16.3557%
6.175%
11.864%
8.8928%
12.5714%
10.7377%
4.907%
5.7977%
11.2277%
7.693%
15.0104%
6.1771%
9.8599%
6.4214%
8.5496%
9.2297%
17.3749%
13.1964%
11.8932%
23.051%
17.6897%
6.9976%
8.808%
9.8562%
14.2725%
10.8478%
3.7846%
4.3598%
8.5183%
7.7477%
22.7795%
7.817%
17.8167%
13.6376%
15.0499%
12.2082%
44.3819%
18.4098%
29.5395%
9.4882%
45.4972%
7.8056%
7.3135%
5.7952%
10.7479%
35.1479%
12.2065%
5.9283%
7.3699%
12.165%
6.9277%
12.9056%
16.2243%
8.6705%
20.2869%
46.8084%
62.3488%
10.2372%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.